Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase

Bioorg Med Chem. 2009 Aug 1;17(15):5696-707. doi: 10.1016/j.bmc.2009.05.080. Epub 2009 Jun 6.

Abstract

Glucopyranosylidene-spiro-1,4,2-oxathiazoles were prepared in high yields by NBS-mediated spiro-cyclization of the corresponding glucosyl-hydroximothioates. In an effort to synthesize analogous glucopyranosylidene-spiro-1,2,4-oxadiazolines, with a nitrogen atom instead of the sulphur, attempted cyclizations resulted in aromatization of the heterocycle with opening of the pyranosyl ring. Enzymatic measurements showed that some of the glucose-based inhibitors were active in the micromolar range. The 2-naphthyl-substituted 1,4,2-oxathiazole displayed the best inhibition against RMGPb (K(i)=160 nM), among glucose-based inhibitors known to date.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Glucose / analogs & derivatives*
  • Glucose / chemical synthesis
  • Glucose / chemistry
  • Glucose / pharmacology
  • Glycogen Phosphorylase, Muscle Form / antagonists & inhibitors*
  • Glycogen Phosphorylase, Muscle Form / metabolism*
  • Molecular Structure
  • Rabbits
  • Structure-Activity Relationship
  • Thiazoles / chemical synthesis*
  • Thiazoles / chemistry
  • Thiazoles / pharmacology*

Substances

  • Thiazoles
  • glucopyranosylidene-spiro-oxathiazole
  • Glycogen Phosphorylase, Muscle Form
  • Glucose